HER-2/neu vaccines.

Mary L. Disis; Kathy Schiffman; Lupe G. Salazar; Bond Almand; Keith L. Knutson

doi:10.1016/s0921-4410(03)21013-9

HER-2/neu vaccines.

Mary L. Disis, Kathy Schiffman, Lupe G. Salazar, Bond Almand, Keith L. Knutson

Jacksonville, FL

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	275-285
Number of pages	11
Journal	Cancer chemotherapy and biological response modifiers
Volume	21
DOIs	https://doi.org/10.1016/s0921-4410(03)21013-9
State	Published - 2003

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/s0921-4410(03)21013-9

Cite this

@article{8b556d80feb143bcb35f212c32486189,

title = "HER-2/neu vaccines.",

author = "Disis, {Mary L.} and Kathy Schiffman and Salazar, {Lupe G.} and Bond Almand and Knutson, {Keith L.}",

note = "Funding Information: This work is supported for MLD by grants from the NIH, NCI (R01 CA75163 and CA85374, and K24 CA 85218) as well as funding from the Cancer Research Treatment Foundation, for LS by NIH training grant T32 (HL07093), and for KLK by a fellowship from the Department of Defense Breast Cancer Program. We thank Ms. Chalie Livingston for assistance in manuscript preparation.",

year = "2003",

doi = "10.1016/s0921-4410(03)21013-9",

language = "English (US)",

volume = "21",

pages = "275--285",

journal = "Cancer chemotherapy and biological response modifiers",

issn = "0921-4410",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - HER-2/neu vaccines.

AU - Disis, Mary L.

AU - Schiffman, Kathy

AU - Salazar, Lupe G.

AU - Almand, Bond

AU - Knutson, Keith L.

N1 - Funding Information: This work is supported for MLD by grants from the NIH, NCI (R01 CA75163 and CA85374, and K24 CA 85218) as well as funding from the Cancer Research Treatment Foundation, for LS by NIH training grant T32 (HL07093), and for KLK by a fellowship from the Department of Defense Breast Cancer Program. We thank Ms. Chalie Livingston for assistance in manuscript preparation.

PY - 2003

Y1 - 2003

UR - http://www.scopus.com/inward/record.url?scp=4444329076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444329076&partnerID=8YFLogxK

U2 - 10.1016/s0921-4410(03)21013-9

DO - 10.1016/s0921-4410(03)21013-9

M3 - Review article

C2 - 15338750

AN - SCOPUS:4444329076

SN - 0921-4410

VL - 21

SP - 275

EP - 285

JO - Cancer chemotherapy and biological response modifiers

JF - Cancer chemotherapy and biological response modifiers

ER -

HER-2/neu vaccines.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this